Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu-Sheng Chou

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Early Human Development|April 28, 2026
The impact of bronchopulmonary dysplasia on post‑neonatal intensive care treatment for retinopathy of prematurity in very preterm infantsKim-Chi T Bui, Fu-Sheng Chou, Qiaoling Chen, et al.
Blood|February 17, 2012
The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETOFu-Sheng Chou, Andrea Griesinger, Mark Wunderlich, et al.
BMC Pediatrics|September 13, 2022
Machine learning for prediction of bronchopulmonary dysplasia-free survival among very preterm infantsRebekah M Leigh, Andrew Pham, Srinandini S Rao, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|January 15, 2023
The association between bronchopulmonary dysplasia grade and risks of adverse neurodevelopmental outcomes among preterm infants born at less than 30 weeks of gestationIzabela Oluwole, John B C Tan, Shirin DeSouza, et al.
Blood|September 24, 2011
Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemiaBenjamin Mizukawa, Junping Wei, Mahesh Shrestha, et al.
Endocrine-Related Cancer|July 20, 2007
Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202Manali Mody, Nachiket Dharker, Mark Bloomston, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Early Human Development|April 28, 2026
The impact of bronchopulmonary dysplasia on post‑neonatal intensive care treatment for retinopathy of prematurity in very preterm infantsKim-Chi T Bui, Fu-Sheng Chou, Qiaoling Chen, et al.
Blood|February 17, 2012
The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETOFu-Sheng Chou, Andrea Griesinger, Mark Wunderlich, et al.
BMC Pediatrics|September 13, 2022
Machine learning for prediction of bronchopulmonary dysplasia-free survival among very preterm infantsRebekah M Leigh, Andrew Pham, Srinandini S Rao, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|January 15, 2023
The association between bronchopulmonary dysplasia grade and risks of adverse neurodevelopmental outcomes among preterm infants born at less than 30 weeks of gestationIzabela Oluwole, John B C Tan, Shirin DeSouza, et al.
Blood|September 24, 2011
Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemiaBenjamin Mizukawa, Junping Wei, Mahesh Shrestha, et al.
Endocrine-Related Cancer|July 20, 2007
Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202Manali Mody, Nachiket Dharker, Mark Bloomston, et al.
Pageof 6